HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.

Abstract
Chromosomal translocations that fuse the mixed lineage leukemia (MLL) gene with multiple partners typify acute leukemias of infancy as well as therapy-related leukemias. We utilized a conditional knockin strategy to bypass the embryonic lethality caused by MLL-CBP expression and to assess the immediate effects of induced MLL-CBP expression on hematopoiesis. Within days of activating MLL-CBP, the fusion protein selectively expanded granulocyte/macrophage progenitors (GMP) and enhanced their self-renewal/proliferation. MLL-CBP altered the gene expression program of GMP, upregulating a subset of genes including Hox a9. Inhibition of Hox a9 expression by RNA interference demonstrated that MLL-CBP required Hox a9 for its enhanced cell expansion. Following exposure to sublethal gamma-irradiation or N-ethyl-N-nitrosourea (ENU), MLL-CBP mice developed myelomonocytic hyperplasia and progressed to fatal myeloproliferative disorders. These represented the spectrum of therapy-induced acute myelomonocytic leukemia/chronic myelomonocytic leukemia/myelodysplastic/myeloproliferative disorder similar to that seen in humans possessing the t(11;16). This model of MLL-CBP therapy-related myeloproliferative disease demonstrates the selectivity of this MLL fusion for GMP cells and its ability to initiate leukemogenesis in conjunction with cooperating mutations.
AuthorsJing Wang, Hiromi Iwasaki, Andrei Krivtsov, Phillip G Febbo, Aaron R Thorner, Patricia Ernst, Ema Anastasiadou, Jeffery L Kutok, Scott C Kogan, Sandra S Zinkel, Jill K Fisher, Jay L Hess, Todd R Golub, Scott A Armstrong, Koichi Akashi, Stanley J Korsmeyer
JournalThe EMBO journal (EMBO J) Vol. 24 Issue 2 Pg. 368-81 (Jan 26 2005) ISSN: 0261-4189 [Print] England
PMID15635450 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA-Binding Proteins
  • Nuclear Proteins
  • Trans-Activators
  • Transcription Factors
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase
  • Kmt2a protein, mouse
  • CREB-Binding Protein
  • Crebbp protein, mouse
Topics
  • Animals
  • CREB-Binding Protein
  • DNA-Binding Proteins (physiology)
  • Histone-Lysine N-Methyltransferase
  • Mice
  • Molecular Sequence Data
  • Myeloid-Lymphoid Leukemia Protein
  • Myeloproliferative Disorders (chemically induced)
  • Nuclear Proteins (physiology)
  • Proto-Oncogenes (physiology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Trans-Activators (physiology)
  • Transcription Factors (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: